StrideBio’s therapeutic programs (STRX) currently include potential in vivo treatments in development with key partners for Friedreich's Ataxia, Niemann-Pick Disease Type C (NPC), Angelman Syndrome, Dravet Syndrome and Rett Syndrome.
Niemann Pick Disease Type C
Patient and Family Resources
Here are a few of the many worthy organizations that provide resources and more information about Friedreich’s Ataxia, Niemann-Pick Disease Type C (NPC), Angelman Syndrome, Dravet Syndrome and Rett Syndrome. The links below are external sites maintained by the respective organizations who are solely responsible for content.
Niemann-Pick Disease Type C (NPC)
StrideBio is deeply motivated and committed to advancing potential treatments to address these serious and rare diseases and we appreciate your interest in our development programs. Patient and advocacy communities contribute greatly to our understanding of these diseases, and it is our desire to work closely with these groups as we advance our programs.